Tandem Diabetes Care
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tandem Diabetes Care generated cash of -$31,810,000, which is less than the previous year. Cash used in financing activities reached the amount of $4,113,000 last year. Net change in cash is therefore -$113,649,000.
Cash Flow
| 2014 | -61.37M | -35.47M | 3.63M |
|---|---|---|---|
| 2015 | -58.76M | 2.42M | 68.25M |
| 2016 | -61.17M | 10.44M | 52.31M |
| 2017 | -66.13M | 2.78M | 32.37M |
| 2018 | -8.31M | -90.73M | 117.18M |
| 2019 | 41.90M | -56.95M | 24.20M |
| 2020 | 24.66M | -296.05M | 314.43M |
| 2021 | 111.35M | -186.87M | 51.93M |
| 2022 | 50.46M | 33.16M | 16.87M |
| 2023 | -31.81M | -85.74M | 4.11M |
TNDM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 172.51M | 71.18M | 94.61M | 51.17M | 41.82M | 23.7M | 44.67M | 43.08M | 31.17M | 124.38M |
Operating activities | ||||||||||
Net income | -222.61M | -94.59M | 15.56M | -34.38M | -24.75M | -122.61M | -73.03M | -83.44M | -72.41M | -79.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 15.71M | 14.33M | 13.84M | 10.45M | 6.07M | 5.82M | 6.86M | 5.48M | 4.82M | 4.38M |
Stock-based compensation expense | 88.07M | 84.91M | 60.75M | 58.43M | 58.07M | 0 | 12.62M | 11.66M | 13.09M | 14.99M |
| Deferred income tax benefit | 88.07M | 84.91M | 60.75M | 58.43M | 58.07M | 0 | 12.62M | 11.66M | 13.09M | 14.99M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 4.27M | -7.83M | -30.98M | -38.83M | -13.69M | -15.84M | -10.44M | 2.25M | -6.47M | -2.54M |
Inventories | -46.05M | -42.45M | -4.95M | -15.36M | -30.97M | 6.75M | -5.89M | -6.90M | -6.08M | -1.82M |
Accounts payable | -4.86M | 24.49M | 10.27M | 1.11M | 8.91M | 1.64M | -1.95M | 3.23M | 3.35M | -1.22M |
Cash generated by operating activities | -31.81M | 50.46M | 111.35M | 24.66M | 41.90M | -8.31M | -66.13M | -61.17M | -58.76M | -61.37M |
Investing activities | ||||||||||
Purchases Of Investments | -510.85M | -467.65M | -733.38M | -497.07M | -164.57M | -123.55M | 0 | -30.62M | -80.19M | -67.10M |
Investments In Property Plant And Equipment | -26.80M | -42.95M | -23.51M | -32.29M | -19.54M | -2.98M | -5.71M | -8.93M | -5.83M | -4.57M |
Acquisitions Net | -69.49M | -25.72M | 9.33M | 4.88M | 37.41M | 1.70M | 0 | -10.46M | 74K | 173K |
Cash generated by investing activities | -85.74M | 33.16M | -186.87M | -296.05M | -56.95M | -90.73M | 2.78M | 10.44M | 2.42M | -35.47M |
Financing activities | ||||||||||
Common Stock Issued | 4.18M | 17.46M | 51.34M | 66.86M | 23.88M | 172.92M | 39.80M | 2.32M | 68.25M | 3.66M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -244.62M | 0 | -87.71M | 0 | 0 | 0 | -30M |
Cash used in financing activities | 4.11M | 16.87M | 51.93M | 314.43M | 24.20M | 117.18M | 32.37M | 52.31M | 68.25M | 3.63M |
Net Change In Cash | -113.64M | 101.33M | -23.43M | 43.43M | 9.34M | 18.12M | -30.97M | 1.59M | 11.91M | -93.20M |
Cash at end of period | 58.86M | 172.51M | 71.18M | 94.61M | 51.17M | 41.82M | 13.7M | 44.67M | 43.08M | 31.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |